Eli Lilly and Co
(BSP:LILY34)
R$
130.52
-2.2 (-1.66%)
Market Cap: 3.72 Til
Enterprise Value: 3.84 Til
PE Ratio: 113.84
PB Ratio: 56.38
GF Score: 73/100 Eli Lilly and Co to Discuss ADA Presentations and Diabetes Portfolio Transcript
Jun 10, 2019 / 02:00PM GMT
Release Date Price:
R$15.75
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot